Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients
ClinicalTrials.gov study NCT00695994. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine
ClinicalTrials.gov study NCT00397787. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
ClinicalTrials.gov study NCT00217555. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors
ClinicalTrials.gov study NCT00678977. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
ClinicalTrials.gov study NCT00012220. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial
ClinicalTrials.gov study NCT02181101. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT00003546. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24)
ClinicalTrials.gov study NCT02363751. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
ClinicalTrials.gov study NCT01291615. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
ClinicalTrials.gov study NCT00052468. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC
ClinicalTrials.gov study NCT00601159. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
ClinicalTrials.gov study NCT00004095. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT02546934. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma (SeliSarc)
ClinicalTrials.gov study NCT06114004. IPD Sharing: NO. Countries: 1. Publications: 48.
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
ClinicalTrials.gov study NCT05285358. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer
ClinicalTrials.gov study NCT00498225. IPD Sharing: Not stated. Countries: 2. Publications: 5.
A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT02425137. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT00075452. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies
ClinicalTrials.gov study NCT03043547. IPD Sharing: NO. Countries: 1. Publications: 2.
Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT02263495. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.